HAP Trading’s Medicines Co MDCO Stock Holding History

HAP Trading’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-56,257	Closed	-$4.78M	–	1650
2019 Q4	$4.78M	Buy	56,257 +17,179	+44%	+$1.15M	0.26%	67
2019 Q3	$1.95M	Sell	39,078 -11,120	-22%	-$444K	0.16%	119
2019 Q2	$1.83M	Sell	50,198 -116,637	-70%	-$3.81M	0.14%	125
2019 Q1	$4.66M	Buy	+166,835	New	+$3.93M	0.42%	58
2017 Q3	–	Sell	-26,809	Closed	-$988K	–	1153
2017 Q2	$1.02M	Buy	+26,809	New	+$1.19M	0.05%	257
2015 Q3	–	Sell	-28,461	Closed	-$814K	–	1248
2015 Q2	$814K	Sell	28,461 -8,239	-22%	-$230K	0.05%	293
2015 Q1	$1.03M	Buy	+36,700	New	+$1.03M	0.07%	239

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

HAP Trading's MDCO Position: Q1 2020 in Review

HAP Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 56,257 shares — an estimated $4.78M sold.

HAP Trading first reported a position in MDCO in Q1 2015 and held it in 7 quarters. The position peaked at $4.78M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

HAP Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
HAP Trading sold 56,257 Medicines Co shares in Q1 2020, an estimated $4.78M.
HAP Trading first reported a position in Medicines Co in Q1 2015 and held it in 7 quarters.
HAP Trading's Medicines Co position peaked at $4.78M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on HAP Trading's 13F filing for Q1 2020, filed 8 May 2020.